| ID: | 152 | |
|---|---|---|
| Name: | Compound 152 | |
| Description: | Original numeration in publication: 5b | |
| Labels: | Test_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C29H20ClN3O/c30-26-13-7-4-8-20(26)16-19-27(34)21-14-17-23(18-15-21)31-29-25-12-6-5-11-24(25)28(32-33-29)22-9-2-1-3-10-22/h1-19H,(H,31,33)/b19-16+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.2 |
Khedr, F.; Ibrahim, M.-K.; Eissa, I. H. a. A., H. S.; El-Adl, K. Phthalazine-based VEGFR-2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations. Arch. Pharm. (Weinheim) 2021, 354, e2100201. https://doi.org/10.1002/ardp.202100201 |
| 6.2666 |
Eq1: VEGFR-2 inhibition (Data used to validate model) |